M. Bas, H. Bier, J. Greve, G. Kojda i inni. Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant. „Allergy”. 12 (61), s. 1490–1492, grudzień 2006. DOI: 10.1111/j.1398-9995.2006.01197.x. PMID: 17073887.
N.L. Cruden, D.E. Newby. Therapeutic potential of icatibant (HOE-140, JE-049). „Expert opinion on pharmacotherapy”. 13 (9), s. 2383–2390, wrzesień 2008. DOI: 10.1517/14656566.9.13.2383. PMID: 18710362.
M. Bas, T.K. Hoffmann, G. Kojda, H. Bier. ACE-inhibitor induced angioedema. „Laryngo- rhino- otologie”. 11 (86), s. 804–812, listopad 2007. DOI: 10.1055/s-2007-966932. PMID: 17966084.
dx.doi.org
K.K.BorkK.K. i inni, Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant), „The Journal of allergy and clinical immunology”, 119, 6, 2007, s. 1497–1503, DOI: 10.1016/j.jaci.2007.02.012, PMID: 17418383.
M. Bas, H. Bier, J. Greve, G. Kojda i inni. Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant. „Allergy”. 12 (61), s. 1490–1492, grudzień 2006. DOI: 10.1111/j.1398-9995.2006.01197.x. PMID: 17073887.
A. Muszyńska, A.M. Fal. [Hereditary angioedema–treatment]. „Polski merkuriusz lekarski”. 145 (25), s. 94–96, lipiec 2008. PMID: 18839625.
N.L. Cruden, D.E. Newby. Therapeutic potential of icatibant (HOE-140, JE-049). „Expert opinion on pharmacotherapy”. 13 (9), s. 2383–2390, wrzesień 2008. DOI: 10.1517/14656566.9.13.2383. PMID: 18710362.
K.K.BorkK.K. i inni, Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant), „The Journal of allergy and clinical immunology”, 119, 6, 2007, s. 1497–1503, DOI: 10.1016/j.jaci.2007.02.012, PMID: 17418383.
M. Bas, T.K. Hoffmann, G. Kojda, H. Bier. ACE-inhibitor induced angioedema. „Laryngo- rhino- otologie”. 11 (86), s. 804–812, listopad 2007. DOI: 10.1055/s-2007-966932. PMID: 17966084.